Skin cancer chemoprevention by α-santalol

Frontiers in Bioscience - Scholar

Volumn 3 S, Issue 2, 2011, Pages 777-787

  Zhang, Xiaoying ^a   Dwivedi, Chandradhar ^b  

^a Shanghai ChemPartner Co Ltd   (China)

^b SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Alphasantalol; Cancer; Chemoprevention; Review; Skin

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; CURCUMIN; CYTOCHROME C; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIGALLOCATECHIN GALLATE; ESSENTIAL OIL; GREEN TEA POLYPHENOL; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLINOSITOL 3 KINASE; POLYPHENOL DERIVATIVE; RESVERATROL; SANTALOL; SILIBININ; SILYMARIN; SURVIVIN; UNCLASSIFIED DRUG; HERBACEOUS AGENT; SANDALWOOD OIL; SESQUITERPENE; VEGETABLE OIL;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CELL CYCLE PROGRESSION; CHEMOPROPHYLAXIS; CYTOTOXIC T LYMPHOCYTE; DNA DAMAGE CHECKPOINT; DOSE RESPONSE; ENVIRONMENTAL FACTOR; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; M PHASE CELL CYCLE CHECKPOINT; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; NONHUMAN; RACEMIC MIXTURE; SANTALUM; SKIN CANCER; SKIN CARCINOGENESIS; SKIN PAPILLOMA; TUMOR MICROENVIRONMENT; TUMOR PROMOTION; ULTRAVIOLET B RADIATION; ULTRAVIOLET C RADIATION; ANIMAL; CELL CYCLE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; METHODOLOGY; MOUSE; MOUSE MUTANT; PHYTOTHERAPY; REVIEW; SANTALACEAE; SKIN TUMOR; TUMOR CELL LINE;

ANIMALIA; MUS;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; DRUGS, CHINESE HERBAL; HUMANS; MICE; MICE, MUTANT STRAINS; PHYTOTHERAPY; PLANT OILS; SANTALUM; SESQUITERPENES; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE;

EID: 79955977394     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Cancer Facts & Figures-2009. In: American Cancer Society, (2009)
2. S. M. Meeran, S. K. Mantena, C. A. Elmets and S. K. Katiyar: (-)-Epigallocatechin-3-gallate prevents photocarcinogenesis in mice through interleukin-12- dependent DNA repair. Cancer Res, 66(10), 5512-20 (2006) (Pubitemid 43844980)
3. M. F. Naylor, A. Boyd, D. W. Smith, G. S. Cameron, D. Hubbard and K. H. Neldner: High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch Dermatol, 131(2), 170-5 (1995)
4. N. Yusuf, C. Irby, S. K. Katiyar and C. A. Elmets: Photoprotective effects of green tea polyphenols. Photodermatol Photoimmunol Photomed, 23(1), 48-56 (2007) (Pubitemid 46189311)
5. Sunsmart: In: http://www.sunsmart.com.au/skin-cancer/types-of-skin-ca ncer
6. C. Hamm, S. Verma, T. Petrella, K. Bak and M. Charette: Biochemotherapy for the treatment of meta static malignant melanoma: a systematic review. Cancer Treat Rev, 34(2), 145-56 (2008)
7. D. S. Preston and R. S. Stern: Nonmelanoma cancers of the skin. N Engl J Med, 327(23), 1649-62 (1992)
8. R. D. Granstein: Evidence that sunscreens prevent UV radiation-induced immunosuppression in humans. Sunscreens have their day in the sun. Arch Dermatol, 131(10), 1201-4 (1995)
9. A. F. Jerant, J. T. Johnson, C. D. Sheridan and T. J. Caffrey: Early detection and treatment of skin cancer. Am Fam Physician, 62(2), 357-68, 375-6, 381-2 (2000)
10. R. Marks: An overview of skin cancers. Incidence and causation. Cancer, 75(2 Suppl), 607-12 (1995)
11. J. C. Barrett and R. W. Wiseman: Cellular and molecular mechanisms of multistep carcinogenesis: relevance to carcinogen risk assessment. Environ Health Perspect, 76, 65-70 (1987) (Pubitemid 18075924)
12. R. K. Boutwell: Some biological aspects of skin carcinogenesis. Prog Exp Tumor Res, 4, 207-250 (1984)
13. J. J. Reiners, Jr., S. Nesnow and T. J. Slaga: Murine susceptibility to two-stage skin carcinogenesis is influenced by the agent used for promotion. Carcinogenesis, 5(3), 301-7 (1984) (Pubitemid 14144422)
14. J. DiGiovanni, T. J. Slaga and R. K. Boutwell: Comparison of the tumor-initiating activity of 7,12- dimethylbenz[a]anthracene and benzo[a]pyrene in female SENCAR and CS-1 mice. Carcinogenesis, 1(5), 381-9 (1980) (Pubitemid 11134278)
15. R. K. Boutwell: The function and mechanism of promoters of carcinogenesis. CRC Crit Rev Toxicol, 2(4), 419-43 (1974)
16. J. C. Barrett: Mechanisms of multistep carcinogenesis and carcinogen risk assessment. Environ Health Perspect, 100, 9-20 (1993) (Pubitemid 23197088)
17. E. M. Griner and M. G. Kazanietz: Protein kina se C and other diacylglycerol effectors in cancer. Nat Rev Cancer, 7(4), 281-94 (2007) (Pubitemid 46480971)
18. K. H. Kraemer: Sunlight and skin cancer: another link revealed. Proc Natl Acad Sci U S A, 94(1), 11-4 (1997) (Pubitemid 27027155)
19. H. Soehnge, A. Ouhtit and O. N. Ananthaswamy: Mechanisms of induction of skin cancer by UV radiation. Front Biosci, 2, d538-51 (1997)
20. I. Willis, J. M. Menter and H. J. Whyte: The rapid induction of cancers in the hairless mouse utilizing the principle of photoaugmentation. J Invest Dermatol, 76(5), 404-8 (1981) (Pubitemid 12168497)
21. G. T. Bowden: Prevention of non-melanoma skin cancer by targeting ultraviolet-B-light signalling. Nat Rev Cancer, 4(1), 23-35 (2004) (Pubitemid 38082151)
22. D. E. Brash, J. A. Rudolph, J. A. Simon, A. Lin, G. J. McKenna, H. P. Baden, A. J. Halperin and J. Ponten: A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A, 88(22), 10124-8 (1991) (Pubitemid 21915787)
23. Y. S. Wan, Z. Q. Wang, Y. Shao, J. J. Voorhees and G. J. Fisher: Ultraviolet irradiation activates PI 3- kinase/AKT survival pathway via EGF receptors in human skin in vivo. Int J Oncol, 18(3), 461-6 (2001)
24. W. Chen, Q. Tang, M. S. Gonzales and G. T. Bowden: Role of p38 MAP kinases and ERK in mediating ultraviolet-B induced cyclooxygenase-2 gene expression in human keratinocytes. Oncogene, 20(29), 3921-6 (2001) (Pubitemid 32646203)
25. Y. Kabuyama, M. Hamaya and Y. Homma: Wavelength specific activation of PI 3-kinase by UVB irradiation. FEBS Lett, 441(2), 297-301 (1998) (Pubitemid 29027914)
26. S. H. Yuspa: The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis - thirty-third G. H. A. Clowes Memorial Award Lecture. Cancer Res, 54(5), 1178-89 (1994) (Pubitemid 24108054)
27. L. W. Wattenberg: Chemoprevention of cancer. Cancer Res, 45(1), 1-8 (1985) (Pubitemid 15196921)
28. M. B. Sporn and N. Suh: Chemoprevention of cancer. Carcinogenesis, 21(3), 525-30 (2000) (Pubitemid 30137938)
29. L. W. Wattenberg: Chemoprevention of cancer by naturally occurring and synthetic compounds. In: Cancer chemoprevention. Ed L. W. Wattenberg, M. Lipkin, C. W. Boone&G. J. Kelloff. CRC Press, Boca Raton (1992)
30. M. M. Manson: Cancer prevention - the potential for diet to modulate molecular signalling. Trends Mol Med, 9(1), 11-8 (2003) (Pubitemid 36139250)
31. M. S. Baliga and S. K. Katiyar: Chemoprevention of photocarcinogenesis by selected dietary botanicals. Photochem Photobiol Sci, 5(2), 243-53 (2006) (Pubitemid 43228052)
32. S. K. Mantena, S. M. Meeran, C. A. Elmets and S. K. Katiyar: Orally administered green tea polyphenols prevent ultraviolet radiation-induced skin cancer in mice through activation of cytotoxic T cells and inhibition of angiogenesis in tumors. J Nutr, 135(12), 2871-7 (2005) (Pubitemid 43156556)
33. S. Katiyar, C. A. Elmets and S. K. Katiyar: Green tea and skin cancer: photoimmunology, angiogenesis and DNA repair. J Nutr Biochem, 18(5), 287-96 (2007) (Pubitemid 46590717)
34. N. Bouzari, Y. Romagosa and R. S. Kirsner: Green tea prevents skin cancer by two mechanisms. J Invest Dermatol, 129(5), 1054 (2009)
35. Y. C. Liang, S. Y. Lin-shiau, C. F. Chen and J. K. Lin: Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J Cell Biochem, 67(1), 55-65 (1997)
36. M. H. Aziz, S. Reagan-Shaw, J. Wu, B. J. Longley and N. Ahmad: Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease? Faseb Journal, 19(9), 1193-5 (2005) (Pubitemid 40946462)
37. P. Roy, N. Kalra, S. Prasad, J. George and Y. Shukla: Chemopreventive potential of resveratrol in mouse skin tumors through regulation of mitochondrial and PI3K/AKT signaling pathways. Pharm Res, 26(1), 211-7 (2009)
38. N. Kalra, P. Roy, S. Prasad and Y. Shukla: Resveratrol induces apoptosis involving mitochondrial pathways in mouse skin tumorigenesis. Life Sci, 82(7-8), 348-58 (2008)
39. J. K. Kundu, K. S. Chun, S. O. Kim and Y. J. Surh: Resveratrol inhibits phorbol ester-induced cyclooxygenase- 2 expression in mouse skin: MAPKs and AP-1 as potential molecular targets. Biofactors, 21(1- 4), 33-9 (2004) (Pubitemid 40921823)
40. J. K. Kundu, Y. K. Shin, S. H. Kim and Y. J. Surh: Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-kappaB in mouse skin by blocking IkappaB kinase activity. Carcinogenesis, 27(7), 1465-74 (2006) (Pubitemid 43994860)
41. K. S. Chun, Y. S. Keum, S. S. Han, Y. S. Song, S. H. Kim and Y. J. Surh: Curcumin inhibits phorbol esterinduced exp ression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation. Carcinogenesis, 24(9), 1515-24 (2003) (Pubitemid 37160842)
42. M. T. Huang, Z. Y. Wang, C. A. Georgiadis, J. D. Laskin and A. H. Conney: Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7,12- dimethylbenz[a]anthracene. Carcinogenesis, 13(11), 2183-6 (1992)
43. J. A. Bush, K. J. Cheung, Jr. and G. Li: Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp Cell Res, 271(2), 305-14 (2001) (Pubitemid 33141212)
44. S. K. Katiyar: Silymarin and skin cancer prevention: anti-inflammatory, antioxidant and immunomodulatory effects (Review). Int J Oncol, 26(1), 169-76 (2005)
45. N. Ahmad, H. Gali, S. Javed and R. Agarwal: Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progr ession. Biochem Biophys Res Commun, 247(2), 294-301 (1998) (Pubitemid 28420816)
46. X. Zi, H. Mukhtar and R. Agarwal: Novel cancer chemopreventive effects of a flavonoid antioxidant silymarin: inhibition of mRNA expression of an endogenous tumor promoter TNF alpha. Biochem Biophys Res Commun, 239(1), 334-9 (1997) (Pubitemid 27480366)
47. X. Zi and R. Agarwal: Modulation of mitogen-activated protein kinase activation and cell cycle regulators by the potent skin cancer preventive agent silymarin. Biochem Biophys Res Commun, 263(2), 528-36 (1999) (Pubitemid 29467229)
48. R. P. Singh and R. Agarwal: Mechanisms and preclinical efficacy of silibinin i n preventing skin cancer. European Journal of Cancer, 41(13), 1969-1979 (2005) (Pubitemid 41557682)
49. G. Mallikarjuna, S. Dhanalakshmi, R. P. Singh, C. Agarwal and R. Agarwal: Silibinin protects against ph otocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling. Cancer Res, 64(17), 6349-56 (2004) (Pubitemid 39129441)
50. S. Banerjee, A. Ecavade and A. R. Rao: Mod ulatory influence of sandalwood oil on mouse hepatic glutathione S-transferase activity and acid soluble sulphydryl level. Cancer Lett, 68(2- 3), 105-9 (1993) (Pubitemid 23090667)
51. C. Dwivedi and A. Abu-Ghazaleh: Chemopreventive effects of sandalwood oil on skin papillomas in mice. European Journal of Cancer Prevention, 6(4), 399-401 (1997) (Pubitemid 27492126)
52. C. Dwivedi and Y. Zhang: Sandalwood oil prevent skin tumour de velopment in CD1 mice. European Journal of Cancer Prevention, 8(5), 449-55 (1999) (Pubitemid 30048075)
53. C. Dwivedi, X. Guan, W. L. Harmsen, A. L. Voss, D. E. Goetz-Parten, E. M. Koopman, K. M. Johnson, H. B. Valluri and D. P. Matthees: Chemopreventive effects of alpha-santalol on skin tumor development in CD-1 and SENCAR mice. Cancer Epidemiol Biomarkers Prev, 12(2), 151-6 (2003) (Pubitemid 36194005)
54. C. Dwivedi, E. R. Maydew, J. J. Hora, D. M. Ramaeker and X. Guan: Chemopreventive effects of various concentrations of alpha-santalol on skin cancer development in CD-1 mice. European Journal of Cancer Prevention, 14(5), 473-6 (2005) (Pubitemid 41433646)
55. C. Dwivedi, H. B. Valluri, X. Guan and R. Agarwal: Chemopreventive effects of alpha-santalol on ultraviolet B radiation-induced skin tumor development in SKH-1 hairless mice. Carcinogenesis, 27(9), 1917-22 (2006) (Pubitemid 44288673)
56. A. Bommareddy, J. Hora, B. Cornish and C. Dwivedi: Chemoprevention by alpha-santalol on UVB radiationinduced skin tumor development in mice. Anticancer Research, 27(4B), 2185-8 (2007) (Pubitemid 47228052)
57. F. R. de Gruijl and P. D. Forbes: UV-induced skin cancer in a hairless mouse model. Bioessays, 17(7), 651-60 (1995)
58. P. D. Forbes: Relevance of animal models of photocarcinogenesis to humans. Photochem Photobiol, 63(4), 357-62 (1996) (Pubitemid 126468293)
59. R. B. Harris and D. S. Alberts: Strategies for skin canc er prevention. Int J Dermatol, 43(4), 243-51 (2004)
60. H. J. Guchelaar, A. Vermes, I. Vermes and C. Haanen: Apoptosis: molecular mechanisms and implications for cancer chemotherapy. Pharm World Sci, 19(3), 119-25 (1997) (Pubitemid 27334513)
61. J. S. Bertram, L. N. Kolonel and F. L. Meyskens, Jr.: Rationale and strategies for chemoprevention of cancer in humans. Cancer Res, 47(11), 3012-31 (1987) (Pubitemid 17113453)
62. S. Y. Sun, N. Hail, Jr. and R. Lotan: Apoptosis as a novel target for cancer chemoprevention. J Natl Cancer Inst, 96(9), 662-72 (2004) (Pubitemid 38660229)
63. J. F. Kerr, A. H. Wyllie and A. R. Currie: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer, 26(4), 239-57 (1972)
64. P. Geserick, C. Drewniok, M. Hupe, T. L. Haas, P. Diessenbacher, M. R. Sprick, M. P. Schon, F. Henkler, H. Gollnick, H. Walczak and M. Leverkus: Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis. Oncogene, 27(22), 3211-20 (2008) (Pubitemid 351693178)
65. I. M. Ghobrial, T. E. Witzig and A. A. Adjei: Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin, 55(3), 178-94 (2005) (Pubitemid 40826487)
66. H. J. Brady: Apoptosis and leukaemia. Br J Haematol, 123(4), 577-85 (2003) (Pubitemid 37468052)
67. S. Elmore: Apoptosis: a review of programmed cell death. Toxicol Pathol, 35(4), 495-516 (2007) (Pubitemid 46911891)
68. M. Kaur, C. Agarwal, R. P. Singh, X. M. Guan, C. Dwivedi and R. Agarwal: Skin cancer chemopreventive agent, a lpha-santalol, induces apoptotic death of human epidermoid carcinoma A431 cells via caspase activation together with dissipation of mitochondrial membrane potential and cytochrome c release. Carcinogenesis, 26(2), 369-380 (2005) (Pubitemid 40246558)
69. B. L. Arasada, A. Bommareddy, X. Y. Zhang, K. Bremmon and C. Dwivedi: Effects of alpha-santalol on proapoptotic caspases and p53 expression in UVB irradiated mouse skin. Anticancer Research, 28(1A), 129-132 (2008) (Pubitemid 351362891)
70. S. van den Heuvel: Cell-cycle regulation. WormBook, 1-16 (2005)
71. M. T. Park and S. J. Lee: Cell cycle and cancer. J Biochem Mol Biol, 36(1), 60-5 (2003)
72. J. M. Raleigh and M. J. O'Connell: The G(2) DNA damage checkpoint targets both Wee1 and Cdc25. J Cell Sci, 113 ( Pt 10), 1727-36 (2000) (Pubitemid 30333122)
73. S. J. Elledge: Cell cycle checkpoints: preventing an identity crisis. Science, 274(5293), 1664-72 (1996) (Pubitemid 26414889)
74. K. A. Schafer: The cell cycle: a review. Vet Pathol, 35(6), 461-78 (1998) (Pubitemid 128472819)
75. X. Zhang, W. Chen, R. Guillermo, G. Chandrasekher, R. S. Kaushik, A. Young, H. Fahmy and C. Dwivedi: Alpha-santalol, a chemopreventive agent against skin cancer, ca uses G2/M cell cycle arrest in both p53-mutated human epidermoid carcinoma A431 cells and p53 wildtype human melanoma UACC-62 cells. BMC Res Notes, 3, 220 (2010)